Results

Latest quarterly results

Companies that reported quarterly results recently, newest first. Each row compares the reported quarter with the same quarter a year earlier. Figures in USD; revenue and net income in millions.

878 companies in Healthcare reported in the last 30 days · showing 751–800 · updated Wed, Nov 18, 2026

CompanySectorReportedQuarter RevenueRev. YoYNet incomeNI YoYEPSEPS YoY Op. marginMargin chg.Market cap
NBIXNeurocrine Biosciences, Inc. Healthcare Nov 2 Sep '26 $1.12B +41.3% $207M −1.4% $1.96 −3.9% 29.5% −0.6 pp $16.8B
JAZZJazz Pharmaceuticals plc Healthcare Nov 2 Sep '26 $1.24B +10.4% −$483M −292.4% −$7.48 −283.3% -33.3% −38.4 pp $15.5B
BMRNBioMarin Pharmaceutical Inc. Healthcare Nov 2 Sep '26 $1.02B +32.1% −$123M n/m −$0.63 n/m -8.0% −2.0 pp $11.3B
TEMTempus AI, Inc. Healthcare Nov 2 Sep '26 $412M +23.4% −$15.0M n/m −$0.08 n/m -13.8% +4.4 pp $11.2B
HNGEHinge Health, Inc. Healthcare Nov 2 Sep '26 $235M +52.6% $57.0M n/m $0.66 n/m 21.4% +25.4 pp $9.3B
KRYSKrystal Biotech, Inc. Healthcare Nov 2 Sep '26 $127M +29.6% $63.0M −20.3% $2.05 −22.9% 55.9% +13.6 pp $8.8B
AXSMAxsome Therapeutics, Inc. Healthcare Nov 2 Sep '26 $260M +52.0% −$13.0M n/m −$0.25 n/m -4.3% +22.7 pp $7.2B
TVTXTravere Therapeutics, Inc. Healthcare Nov 2 Sep '26 $225M +36.4% −$52.0M −300.0% −$0.55 −320.0% -30.3% −45.5 pp $4.9B
CRSPCRISPR Therapeutics AG Healthcare Nov 2 Sep '26 $13.0M +1,200% −$111M n/m −$1.15 n/m — — $3.9B
INSPInspire Medical Systems, Inc. Healthcare Nov 2 Sep '26pending $207M† −8.1% — — — — — — $1.7B
RXRXRecursion Pharmaceuticals, Inc. Healthcare Nov 2 Sep '26 $19.0M +280.0% −$119M n/m −$0.22 n/m -664.0% — $1.7B
SIBNSI-BONE, Inc. Healthcare Nov 2 Sep '26 $56.0M +14.3% −$4.0M n/m −$0.08 n/m -7.8% +3.3 pp $1.0B
SPTXSeaport Therapeutics, Inc. Healthcare Nov 2 Sep '26 $0.0M — −$26.0M — −$0.49 — — — $973M
HSTMHealthStream, Inc. Healthcare Nov 2 Sep '26pending $83.3M† +9.6% — — — — — — $845M
SNDXSyndax Pharmaceuticals, Inc. Healthcare Nov 2 Sep '26 $83.0M +80.4% −$49.0M n/m $0.00 n/m -50.3% +74.9 pp $828M
BVSBioventus Inc. Healthcare Nov 2 Sep '26 $142M +2.2% $6.0M +100.0% $0.08 +60.0% 6.8% −1.9 pp $726M
TCMDTactile Systems Technology, Inc. Healthcare Nov 2 Sep '26 $92.0M +7.0% $7.0M −12.5% $0.31 −13.9% 10.4% −2.3 pp $584M
CERSCerus Corporation Healthcare Nov 2 Sep '26 $58.0M +9.4% −$1.0M n/m $0.00 n/m 0.7% −1.7 pp $384M
EBSEmergent BioSolutions Inc. Healthcare Nov 2 Sep '26 $110M −52.4% $0.0M −100.0% $0.00 −100.0% 0.0% −33.2 pp $288M
ABBVAbbVie Inc. Healthcare Oct 30 Sep '26 $17.40B +10.3% $4.22B +2,168% $2.38 +2,280% 36.0% +23.9 pp $517.7B
AZNAstraZeneca PLC Healthcare Oct 30 Sep '26pending $16.21B† +6.7% — — — — — — $282.7B
REGNRegeneron Pharmaceuticals, Inc. Healthcare Oct 30 Sep '26pending $5.12B† +36.3% — — — — — — $99.1B
BTSGBrightSpring Health Services, Inc. Healthcare Oct 30 Sep '26 $4.21B +26.4% $100M +78.6% $0.45 +73.1% 3.8% +1.2 pp $13.9B
OGNOrganon & Co. Healthcare Oct 30 Sep '26 $1.57B −1.7% $164M +2.5% $0.60 −1.6% 23.2% +0.8 pp $3.7B
AUPHAurinia Pharmaceuticals Inc Healthcare Oct 30 Sep '26 $84.0M +15.1% $32.0M 0.0% $0.23 0.0% 42.3% +1.8 pp $2.1B
IRMDiRadimed Corporation Healthcare Oct 30 Sep '26 $24.0M +14.3% $7.0M +16.7% $0.51 +18.6% 33.6% +1.4 pp $1.1B
VORVor Biopharma Inc. Healthcare Oct 30 Sep '26 $0.0M n/m −$87.0M n/m −$1.45 n/m — — $985M
OABIOmniAb, Inc. Healthcare Oct 30 Sep '26 $4.0M n/m −$16.0M n/m −$0.12 n/m -404.9% — $737M
MNDRMobile-health Network Solutions Healthcare Oct 30 Sep '26pending $3.0M† n/m — — — — — — $22,882
LLYEli Lilly and Company Healthcare Oct 29 Sep '26pending $24.40B† +38.6% — — — — — — $1.33T
MRKMerck & Company, Inc. Common Stock (new) Healthcare Oct 29 Sep '26pending $18.09B† +5.2% — — — — — — $353.4B
GILDGilead Sciences, Inc. Healthcare Oct 29 Sep '26pending $8.30B† +6.8% — — — — — — $211.2B
BMYBristol-Myers Squibb Company Healthcare Oct 29 Sep '26pending $13.07B† +6.9% — — — — — — $125.4B
SYKStryker Corporation Healthcare Oct 29 Sep '26pending $6.52B† +7.6% — — — — — — $120.9B
RMDResMed Inc. Healthcare Oct 29 Sep '26 $1.42B +5.9% $418M +19.8% $2.92 +23.2% 32.0% −1.4 pp $33.5B
ILMNIllumina, Inc. Healthcare Oct 29 Sep '26pending $1.17B† +7.7% — — — — — — $30.6B
DXCMDexCom, Inc. Healthcare Oct 29 Sep '26pending $1.34B† +11.2% — — — — — — $30.6B
WSTWest Pharmaceutical Services, Inc. Healthcare Oct 29 Sep '26 $875M +8.8% $214M +52.9% $3.02 +56.5% 30.6% +9.0 pp $28.8B
INSMInsmed Incorporated Healthcare Oct 29 Sep '26 $524M +269.0% −$100M n/m −$0.46 n/m -17.0% +240.1 pp $26.7B
INCYIncyte Corporation Healthcare Oct 29 Sep '26 $1.56B +14.0% −$785M −285.1% −$3.86 −282.9% -45.5% −77.1 pp $24.3B
THCTenet Healthcare Corporation Healthcare Oct 29 Sep '26 $6.28B +18.7% $1.00B +192.4% $12.41 +221.5% 27.9% +11.1 pp $22.4B
ALNYAlnylam Pharmaceuticals, Inc. Healthcare Oct 29 Sep '26pending $1.46B† +16.7% — — — — — — $21.0B
EXELExelixis, Inc. Healthcare Oct 29 Sep '26 $659M +10.2% $218M +12.4% $0.85 +21.4% 40.8% +1.2 pp $17.2B
BBIOBridgeBio Pharma, Inc. Healthcare Oct 29 Sep '26 $353M +191.7% −$57.0M n/m −$0.42 n/m -3.3% +117.0 pp $15.0B
BAXBaxter International Inc. Healthcare Oct 29 Sep '26pending $2.98B† +5.0% — — — — — — $13.3B
PENPenumbra, Inc. Healthcare Oct 29 Sep '26 $410M +15.5% $42.0M −8.7% $1.07 −8.5% 12.4% −1.4 pp $12.6B
DVADaVita Inc. Healthcare Oct 29 Sep '26 $3.58B +4.6% $223M +48.7% $3.40 +66.7% 13.9% −0.8 pp $10.9B
KYMRKymera Therapeutics, Inc. Healthcare Oct 29 Sep '26 $0.0M n/m −$132M n/m −$1.32 n/m — — $10.4B
ATRAptarGroup, Inc. Healthcare Oct 29 Sep '26 $1.02B +6.0% $33.0M −74.2% $0.51 −73.4% 13.3% −1.2 pp $8.9B
SUPNSupernus, Inc. Healthcare Oct 29 Sep '26 $227M +18.2% $21.0M n/m $0.35 n/m 9.3% +40.7 pp $6.0B
  • Report dates come from the earnings calendar (dates loaded Oct 4 to Dec 9); figures come from the quarterly statements stored for each company. Click a ticker for its full statements.
  • YoY compares the reported quarter with the same quarter a year earlier. n/m (not meaningful) means the year-earlier figure was zero or negative, so a percentage change would not describe it. Margin change is in percentage points.
  • pending: the company has reported, but that quarter is not in our statements yet. Revenue marked † is the announced figure from the earnings calendar; the other columns fill in once the statements update.

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.